Buy Full EMAT Report

    Price: €120

 

       

 

 

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

 

► Example of EMAT Report

 

EPSILON M&A DEAL REPORT

Transaction Multiples for the Valuation of Private Companies

William Ransom & Son  - Valuation Multiples - Pharmaceuticals

WCM (2011) / William Ransom & Son

28598
04/07/2011
Acquisition of Majority Stake
Yes
WCM (2011)

William Ransom & Son
England
Health, Pharmaceuticals & Biotechnology > Pharmaceuticals & Cosmetics > Pharmaceuticals
Founded in 1846, William Ransom & Son engages in: 1. C ontract manufacturing of licensed pharmaceutical liquids and creams for third parties; and botanical extracts for sale to third parties,...

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic n.s. - - - -
Current - - - - - -
 
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Pharmaceuticals » = 65
Example of comparable transactions on EMAT (same sub-sector):
DateAcquirerTargetCountryMultiplesSee details
01/06/2011 Vetoquinol Farmagricola Brazil
30412
18/11/2011 Euticals Archimica Italy
23431

Source: Epsilon Research / EMAT